New app aims to ease chemo stress for breast cancer patients
NCT ID NCT06977360
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tests a smartphone app called iCareBreast+ designed to help women with breast cancer manage the challenges of chemotherapy. The app provides self-care tools and information to boost confidence and reduce anxiety. The study will enroll 40 women and assess whether the app is easy to use and helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iCareBreast+ smartphone app
- What this could lead to
- If it works, this app could provide a practical, low-cost way to help women with breast cancer feel more confident and less anxious during chemotherapy.
- What could go wrong
- This is a very small pilot study (40 participants) testing feasibility, not effectiveness. The app may not show meaningful benefits, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Centre, Singapore
RECRUITINGSingapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?